Trading Strategies for Thyrocare, Dr Lal Path, Metropolis Amid Covid Scare
Thyrocare, Dr Lal Path Labs and Metropolis are trading almost 50% below their respective all-time highs, the reversal could see a break if the respective key levels hold
Dr Lal PathLabs | Thyrocare Technologies | Coronavirus testing
Avdhout Bagkar |
Last Updated Jun 6, 2022 11:49 IST
Some Indian states, including Maharashtra and Kerala, have seen an increase in daily Covid-19 cases. As authorities have stepped up efforts to control the outbreak by making face masks compulsory in Maharashtra, among other measures, the monsoon season coupled with the reopening of schools and offices could add to authorities’ woes.
TO READ THE FULL STORY, SUBSCRIBE NOW FOR JUST RS 249 PER MONTH.
Key stories on business-standard.com are only available to premium subscribers.
Already a premium subscriber? LOGIN NOW
SUBSCRIBE TO PERSPECTIVES
What do you get on Business Standard Premium?
First published: Monday 06 June 2022. 11:42 IST